CRS 2025 Annual Meeting & Exposition Pre-meeting Workshop: Recent Advances in Oral Peptide Delivery – From Molecule to Market

Join Quotient Sciences along with industry leaders to hear latest insight in oral peptide development and clinical testing.

Systemic delivery of peptides by the oral route is now a reality with multiple products on the market and many more in development. Attendees will learn of the latest advances in oral peptide delivery and its future directions from world leading academics and industry leaders who have successfully taken oral peptide products from preclinical development to translation into the clinic and market launch. Topics covered include fundamental mechanisms, peptide engineering, oral peptide biopharmaceutics, novel drug delivery systems and their clinical development. Insights and learnings will be shared on how to navigate the unique challenges oral peptide programs present and future directions of the field.

Goals and Objectives

• Learn the latest developments in our understanding of oral peptide biopharmaceutics

• Hear the latest progress on the clinical development of oral products from industry leaders

• Share insights and learnings in managing the transition from preclinical to clinical development of oral peptide products

Chairs & Company Sponsors

• Andy Lewis, Chief Scientific Officer, Quotient Sciences
• Stephen Buckley, Vice President, Drug Product Research, Novo Nordisk
• David Brayden, Professor of Advanced Drug Delivery, University College Dublin

*We reserve the right, at our sole discretion, to deny registration or remove any individual who is not a confirmed current or potential client/partner of Quotient Sciences.